HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

İhsan Yılmaz Selected Research

Bevacizumab (Avastin)

6/2017Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal Telangiectasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


İhsan Yılmaz Research Topics

Disease

2Macular Degeneration (Age-Related Maculopathy)
01/2020 - 10/2018
1Telangiectasis (Telangiectasia)
06/2017
1Myopia
01/2016

Drug/Important Bio-Agent (IBA)

2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2020 - 10/2018
1N-acetyltryptophanamide (NATA)IBA
01/2020
1Bevacizumab (Avastin)FDA Link
06/2017

Therapy/Procedure

1Intraocular Lenses (Intraocular Lens)
01/2016